ATTR Amyloidosis clinical trials at UCLA
1 research study open to eligible people
Showing trials for
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
open to all eligible people
The purpose of this study is to: - Describe epidemiological and clinical characteristics, natural history and real-world clinical management of ATTR amyloidosis patients - Characterize the safety and effectiveness of patisiran and vutrisiran as part …
Los Angeles, California and other locations
Our lead scientists for ATTR Amyloidosis research studies include Perry B. Shieh, MD, PhD.
Last updated: